Home
News
Videos
Podcasts
Slides
Visual Abstracts
Topics
Conferences
- SCAI 2018
- ACC 2018
- AHA 2017
- ESC 2017
- SCAI 2017
- ACC 2017

Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab – ODYSSEY Outcomes Trial

By Tarek Nafee, M.D. on March 23, 2018

t f

Sodium Zirconium Cyclosilicate Enables MRA Optimization in HFrEF with Hyperkalemia: Insights from the REALIZE-K Trial

Key Points: REALIZE-K trial was a double-blind, placebo-controlled, randomized withdrawal study investigating SZC’s ability to… Continue Reading

By Alberto Castro Molina
November 29, 2024

Enhanced Efficiency and Accuracy in Echocardiographic Workflow: Insights from the AI-ECHO RCT

Key Points: AI-ECHO RCT is the first randomized trial to evaluate AI-based automated analysis within… Continue Reading

By Alberto Castro Molina
November 29, 2024

Obicetrapib Demonstrates Promising Lipid-Lowering Efficacy and Safety in Heterozygous Familial Hypercholesterolemia: BROOKLYN

Key Points: BROOKLYN was a phase III trial that assessed the safety and effectiveness of… Continue Reading

By Alberto Castro Molina
November 29, 2024

Create an Account

CLICK TO REGISTER

Cardiology Now News is sponsored by the Baim Institute for Clinical Research and produced by the PERFUSE Study Group. Baim and PERFUSE are academic research organizations led by world class cardiovascular clinical trialists and opinion leaders.

Receive the latest news, interviews, podcasts directly to your inbox

Leave a Reply Cancel reply

More from

Sodium Zirconium Cyclosilicate Enables MRA Optimization in HFrEF with Hyperkalemia: Insights from the REALIZE-K Trial

Enhanced Efficiency and Accuracy in Echocardiographic Workflow: Insights from the AI-ECHO RCT

Obicetrapib Demonstrates Promising Lipid-Lowering Efficacy and Safety in Heterozygous Familial Hypercholesterolemia: BROOKLYN